Abstract
Many patients with Stage 1 non-seminomas are now treated by orchidectomy and close follow-up along. Chart review indicated that a group of such patients, compared with patients treated with chemotherapy, tended to be less compliant with follow-up. A questionnaire given to a second sample of patients confirmed that surgical patients underestimated the dangers of the disease and chances of relapse, and doubted the value of follow-up.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, B., Bultz, B., Russell, J. et al. Compliance with follow-up of patients treated for non-seminomatous testicular cancer. Br J Cancer 64, 606–608 (1991). https://doi.org/10.1038/bjc.1991.359
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.359
This article is cited by
-
Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors
Annals of Surgical Oncology (1996)
